{"meta":{"query_hash":"a41a08e23b68","filters":{"venue":"Allergologie select"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a41a08e23b68","api":"https://metacan.xera.ac/api/v1/cohort?venue=Allergologie+select"},"results":[{"id":"W3083890861","doi":"10.5414/alx02166e","title":"Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic","year":2020,"lang":"en","type":"article","venue":"Allergologie select","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Novartis Pharma; Genentech; Lilly Deutschland; European Academy of Allergy and Clinical Immunology; Karl-Franzens-Universität Graz; Allergopharma; Rheinische Friedrich-Wilhelms-Universität Bonn; Syddansk Universitet; Hospital for Sick Children; Karolinska Institutet; Medizinische Universität Wien; National and Kapodistrian University of Athens; University of Toronto; King's Health Partners; King's College London; AstraZeneca; Allergy Therapeutics; Regeneron Pharmaceuticals; Mylan; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Ankara Universitesi; Julius-Maximilians-Universität Würzburg; Universität zu Lübeck; Universidad Complutense de Madrid; Sanofi; Università degli Studi di Cagliari; Philipps-Universität Marburg; Helmholtz Zentrum München; Universität Wien; Universitätsmedizin der Johannes Gutenberg-Universität Mainz; Celgene; Eli Lilly and Company; Medizinische Universität Graz; Universität zu Köln; GlaxoSmithKline; Amgen","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Immune system; Social distance; Intensive care medicine; Atopy; Immunology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Distancing; Allergy; Virology; Disease; Outbreak; Internal medicine","score_opus":0.07876247342619572,"score_gpt":0.3400519859094709,"score_spread":0.26128951248327514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083890861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887278,0.0057159113,0.000024772624,0.004413936,0.00007558143,0.0008273422,0.00001020739,0.0001839958,0.00002042562],"genre_scores_gemma":[0.99195296,0.004630849,0.00006706437,0.0031496983,0.000103041435,0.00003976037,0.000019206587,0.000018745937,0.000018675337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829555,0.00032221002,0.0003864126,0.00043098273,0.00020637242,0.000358469],"domain_scores_gemma":[0.99704206,0.0020651869,0.00014777412,0.00031159003,0.000057208454,0.00037620772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024222213,0.00023295499,0.00047445178,0.00009811551,0.00006973407,0.000017885968,0.00022352388,0.00011933142,0.00005998377],"category_scores_gemma":[0.008123206,0.00014457591,0.000094477844,0.00035351454,0.00028664144,0.00009556536,0.0002349488,0.000393507,0.000014292007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011509958,0.00008424478,0.98508877,0.0006769709,0.00010583311,0.00016063845,0.000294509,0.00037812462,0.0086804945,0.00005643298,0.0011052429,0.0022177391],"study_design_scores_gemma":[0.0020233332,0.00070101797,0.9828411,0.00010144009,0.0000747294,0.00004009319,0.000035304336,0.00041436232,0.00041543317,0.0002203242,0.012896907,0.0002359531],"about_ca_topic_score_codex":0.00004110913,"about_ca_topic_score_gemma":0.000051879866,"teacher_disagreement_score":0.011791663,"about_ca_system_score_codex":0.00013258959,"about_ca_system_score_gemma":0.0004374947,"threshold_uncertainty_score":0.9724823},"labels":[],"label_agreement":null},{"id":"W4400870362","doi":"10.5414/alx02515e","title":"Protocol for the systematic reviews on the desirable and undesirable effects of pharmacological treatments of allergic rhinitis informing the ARIA 2024 guidelines","year":2024,"lang":"en","type":"article","venue":"Allergologie select","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Protocol (science); Medicine; Systematic review; Alternative medicine; MEDLINE; Biology; Pathology","score_opus":0.1872505004517747,"score_gpt":0.4072643136004599,"score_spread":0.2200138131486852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400870362","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04938209,0.023297668,0.0063953893,0.014699003,0.0012351075,0.8953149,0.000020306155,0.00029432532,0.009361213],"genre_scores_gemma":[0.5785165,0.013943826,0.0020680474,0.0037457556,0.0004918853,0.39304346,0.000024745084,0.00010514797,0.008060666],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99811554,0.00033165503,0.0007999989,0.00023942027,0.0002609804,0.00025242014],"domain_scores_gemma":[0.9935926,0.0055866577,0.00027454592,0.00030508154,0.00020358701,0.000037484744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014103386,0.0002433413,0.00062220206,0.000056160545,0.00020555904,0.000040809817,0.00018197381,0.00010412503,0.00006360077],"category_scores_gemma":[0.002106501,0.00008557798,0.00020025184,0.00029381888,0.00014765863,0.000060119142,0.00004989602,0.00019157877,0.00000918179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006181821,0.0019741326,0.0005674928,0.20159899,0.026900414,0.0004774518,0.007873978,0.0026043314,0.045564793,0.07226727,0.5447839,0.08920543],"study_design_scores_gemma":[0.028704004,0.035479322,0.0048982324,0.14157867,0.01935124,0.00200434,0.0040487424,0.43610182,0.13159272,0.01851908,0.17524616,0.0024756575],"about_ca_topic_score_codex":0.00003386135,"about_ca_topic_score_gemma":0.000009541942,"teacher_disagreement_score":0.5291344,"about_ca_system_score_codex":0.000048232356,"about_ca_system_score_gemma":0.00013042572,"threshold_uncertainty_score":0.34897688},"labels":[],"label_agreement":null}]}